[SERM--selective estrogen receptor modulators]
- PMID: 11332210
[SERM--selective estrogen receptor modulators]
Abstract
SERM describes a category of drugs that exert their influence on estrogen-sensitive tissue and are known especially in the treatment of estrogen receptor-positive breast cancer. The development and clinical trials of new SERM in recent years seem to establish more fields of diseases, where treatment with SERM may be indicated.
Similar articles
-
Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health.Int J Fertil Womens Med. 1999 Sep-Oct;44(5):221-6. Int J Fertil Womens Med. 1999. PMID: 10569450 Review.
-
The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.Taiwan J Obstet Gynecol. 2008 Mar;47(1):24-31. doi: 10.1016/S1028-4559(08)60051-0. Taiwan J Obstet Gynecol. 2008. PMID: 18400579 Review.
-
Tamoxifen, raloxifene and the prevention of breast cancer.Minerva Endocrinol. 2002 Jun;27(2):127-39. Minerva Endocrinol. 2002. PMID: 11961504 Review.
-
Selective estrogen-receptor modulators for primary prevention of breast cancer.J Clin Oncol. 2005 Mar 10;23(8):1644-55. doi: 10.1200/JCO.2005.11.005. J Clin Oncol. 2005. PMID: 15755972 Review. No abstract available.
-
[Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].Recenti Prog Med. 2003 Feb;94(2):51-6. Recenti Prog Med. 2003. PMID: 12908369 Review. Italian.